Returning Winners Victorious Again in Jeopardy Tournament

two students, one talking into a microphone.

Madelyne Xiao, right, looks on as partner Nikhil Gowda, center, poses the correct question in the Student Science Jeopardy Tournament on July 17.

By Robin Meckley, Contributing Writer                                          

Every year for the past three years, student interns Madelyne Xiao and Nikhil Gowda have competed in the Scientific Library’s Student Science Jeopardy Tournament, the annual science event for students that mirrors the popular TV show “Jeopardy.” And every year, for the past three years, Xiao and Gowda, who work with Randall Johnson, Ph.D. bioinformatics analyst, Basic Science Program Center for Cancer Research (CCR) Genetics Core, have finished in one of the top three positions.

Tags: 

TYCTWD Programs Strive to Make Science Educational and Fun

Scientist/Wizard magic show.

Joe Barchi dresses up as a wizard to add some excitement to his lab’s Chemical Magic Show at Take Your Child to Work Day on June 25.

By Carolynne Keenan, Contributing Writer

Joseph Barchi, Jr, Ph.D., calls teaching “the noblest and most important profession.” So it makes sense that Barchi, senior scientist and head of the Glycoconjugate and NMR Section, Chemical Biology Laboratory, Center for Cancer Research, NCI at Frederick, would encourage his lab to offer a fun, educational program at Take Your Child to Work Day (TYCTWD).

Tags: 

HIV Integration at Certain Sites in Host DNA Is Linked to the Expansion and Persistence of Infected Cells

See caption for details.

In an untreated patient, most HIV-infected cells die within one or two days. A small fraction of the infected cells is long-lived. Successfully treating a patient with combination antiretroviral therapy (cART) prevents any additional cells from becoming infected, and all of the short-lived infected cells die. Although some long-lived infected cells also die, some long-lived cells persist in patients, preventing them from being cured. Some infected cells can grow and divide, and some of these expanded clones of infected cells, which can be identified by the location of the provirus in the host DNA, can persist for more than 10 years in patients.

Editor’s note: This article was originally published on the Center for Cancer Research website.

When the Human Immunodeficiency Virus (HIV) infects a cell, the virus inserts a copy of its genetic material into the host cell’s DNA. The inserted genetic material, which is also called a provirus, is used to produce new viruses. Because the viral DNA can be inserted at many sites in the host cell DNA, the site of integration marks each infected cell. Patients infected with HIV are currently treated with combined antiretroviral therapy (cART), which prevents viral replication in the majority of treated patients. When cART is initiated, most HIV-infected cells die in one or two days, and more of the infected cells die over a period of weeks to months. However there are some long-lived infected cells that do not die, which prevents patients from being cured.

Tags: 

Former Intern: Amy Stull Returns to Her Roots

Portrait of Amy Stull.

As part of the NIH Management Intern Program, Amy Stull worked in the Office of Scientific Operations, NCI at Frederick, from April to mid-July.

By Carolynne Keenan, Contributing Writer

When Amy Stull, a 2000 graduate of Walkersville High School, began working in a laboratory at the National Cancer Institute (NCI) at Frederick, she likely did not know the role NCI would play in her career.

Stull started at NCI as a Werner H. Kirsten (WHK) student intern after her junior year of high school, working in a lab as she prepared for a career in chemical engineering. The student intern program pairs rising high school seniors with laboratory scientists to encourage the students to pursue careers in both science and health care fields.

Tags: 

Dunk Tank Hits the Mark at Take Your Child To Work Day

Man being dunked in dunk tank.

By Carolynne Keenan, Contributing Writer

Robin Winkler-Pickett has known Jim Cherry, Ph.D., scientific program director, and Craig Reynolds, Ph.D., director, Office of Scientific Operations, both NCI at Frederick, for many years. “We’ve been friends for a long time.”

So when she heard about the chance to dunk each of them at Take Your Child to Work Day (TYCTWD) on June 25, Winkler-Pickett, a research biologist in the Laboratory of Experimental Immunology, NCI Center for Cancer Research, knew she had to make time to participate.

Tags: 

New Mouse Model May Aid in Developing Effective Therapies for Ovarian Cancer

See caption for details.

Allograft models were developed by transplanting tumor fragments into the ovaries of recipient mice. Tumor fragments were obtained from genetically engineered mouse (GEM) models that developed ovarian tumors after the induction of genetic alterations similar to those observed in human patients. These genetic events, within several months, lead to ovarian tumor development similar to what is seen in human serous epithelial ovarian cancer (SEOC). Using murine allograft models of SEOC results in faster tumor growth and allows for large cohort production, which represents a valuable tool for preclinical testing of therapeutic agents.

By Frank Blanchard, Staff Writer

A new genetically engineered mouse model appears promising as an effective tool for preclinical testing of novel therapies for ovarian cancer, which tends to be diagnosed in late stage. There are few effective treatments for the disease.

Tags: 

Pages